08/11/2024  17:37:00 Chg. +0.10 Volume Bid17:40:08 Demandez à08/11/2024 Capitalisation boursière Dividende Y. Rapport P/E
68.40EUR +0.15% 79,456
Chiffrre d'affaires: 5.44 Mio.
-Bid taille: - -Ask la taille: - 1.18 Mrd.EUR 0.31% 49.28

Description de l'entreprise

NEXUS AG is one of Europe's leading software providers in the healthcare sector. The company's software solutions support customers in the procurement of information and medical documentation in particular. In product development, the focus is on simple and fast application by the user. In addition to integrated complete solutions, NEXUS also works as a solution provider for healthcare IT. The company offers solutions for all requirements of healthcare facilities for modern software systems: from patient management, specialist medical solutions with all billing modalities to quality and organizational management. With its IT services, NEXUS offers a further combination of system integration, operation and support for various applications.
 

Conseil d'administration & Conseil de surveillance

PDG
Dr. Ingo Behrendt
Conseil d'administration
Edgar Kuner, Ralf Heilig
Conseil de surveillance
Dr. Hans-Joachim König, Dr. Dietmar Kubis, Prof. Dr. Felicia Mechtild Rosenthal, Rolf Wöhrle, Florian Herger, Juergen Rottler
 

Données de l'entreprise

Nom: NEXUS AG
Adresse: Irmastraße 1,D-78166 Donaueschingen
Téléphone: +49-771-22960-0
Fax: +49-771-22960-999
Courriel: info@nexus-ag.de
Internet: de.nexus-ag.de
Industrie: Technology
Secteur: IT-Services
Sous-secteur: IT Consulting & Services
Fin de l'exercice financier: 31/12
Flotte libre: -
IPO date: 24/07/2000

Relations avec les investisseurs

Nom: -
Téléphone IR: -
IR-Fax: -
E-mail IR: ir@nexus-ag.de

Calendrier de l'entreprise

CW 10 | 04/03/2025 4th Quarter/Annual Report
CW 21 | 20/05/2025 Interim Report 1st Quarter/3 Months
CW 21 | 22/05/2025 General Shareholder Meeting
CW 33 | 12/08/2025 Interim Report 2nd Quarter/6 Months
CW 45 | 04/11/2025 Interim Report 3rd Quarter/9 Months
 

Principaux actionnaires

Autres
 
61.18%
Luxempart
 
10.06%
Brown Capital Management LLC
 
9.18%
FMR LLC
 
9.11%
GUB Venture Capital GmbH & Co. KG aA
 
5.96%
Allianz Global Investors
 
4.51%